ESMO 2018 | Exciting prospects for endometrial cancer treatment

Carien Creutzberg

International collaboration for the treatment of endometrial cancer, led by the ongoing PORTEC-4a trial, may lead to more efficient therapy strategies, hopes Carien Creutzberg, MD, PhD, of the Leiden University Medical Center, Leiden, Netherlands. Real-time analysis of molecular subgroups can speed up the treatment ‘profiling’ process, while smaller phase II trials are paving the way for treatment against advanced or recurrent disease.

Share this video